Literature DB >> 9797477

The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.

C Gross1, A V Krishnan, P J Malloy, T R Eccleshall, X Y Zhao, D Feldman.   

Abstract

The vitamin D receptor (VDR) gene contains a start codon polymorphism (SCP) which is three codons upstream of a second start site (ATG). The SCP genotype can be determined with the restriction enzyme FokI, where "f" indicates the presence of the restriction site and the first ATG, while "F" indicates its absence. Recent evidence suggests that the ff genotype is correlated with lower bone mineral density (BMD) in some populations. The SCP results in alternate VDRs that differ structurally, with the F variant (F-VDR) being three amino acids shorter than the f variant (f-VDR). To determine whether there are functional differences between the f-VDR and the F-VDR, we studied the two VDR forms expressed in COS-7 cells. The proteins were distinguishable from one another on Western blots by their different mobilities, confirming the larger size of f-VDR. Ligand binding studies showed no significant differences between the affinities of the two VDR forms for [3H]-1,25-dihydroxyvitamin D3 ([3H]-1,25(OH)2D3) (Kd = 131+/-78 pM, f-VDR; Kd = 237+/-190 pM, F-VDR; p = 0.24); however, a 2-fold difference in affinity can not be discriminated by this method. There were no differences in the abilities of the two receptor forms to bind DNA as determined by electrophoretic mobility shift assays. The ability of the two VDR forms to transactivate target genes was investigated using three different vitamin D responsive luciferase reporter constructs: 24-hydroxylase, osteocalcin, and osteopontin. In these transactivation experiments, 1,25(OH)2D3 dose-response (0.1-10 nM) curves revealed that the ED50 values for transactivation were indistinguishable between the two VDR forms. Additionally, cultured human fibroblasts with FF, Ff, and ff genotypes had similar sensitivity to 1,25(OH)2D3 with respect to the induction of 24-hydroxylase mRNA. In summary, we were unable to detect significant differences in ligand affinity, DNA binding, or transactivation activity between f-VDR and F-VDR forms. We must emphasize, however, that the sensitivity of the methods used limits our ability to detect minor differences in VDR affinity and function. In conclusion, we cannot define a mechanism whereby the SCP in the VDR might contribute to population differences in BMD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797477     DOI: 10.1359/jbmr.1998.13.11.1691

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  46 in total

Review 1.  Genetics of osteoporosis.

Authors:  S H Ralston
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Vitamin D receptor gene polymorphism and bone mineral density in 0-6-year-old Han children.

Authors:  Xiao-Dan Yu; Xiao-Ming Shen; Ming-Bao Xue; Chong-Huai Yan
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

3.  Meta-Analysis of the Association Between the rs228570 Vitamin D Receptor Gene Polymorphism and Arterial Hypertension Risk.

Authors:  Ivone F O C Nunes; Ana A C M Cavalcante; Marcus V O B Alencar; Marcos D F Carvalho; José L R Sarmento; Nayra S C C A Teixeira; Adriana A Paiva; Lídia R Carvalho; Leopoldo F M Nascimento; Maria S P Cruz; Marcelo M Rogero; Andréia C B Lima; Cecilia M R G Carvalho
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

4.  Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA.

Authors:  Igor Orlov; Natacha Rochel; Dino Moras; Bruno P Klaholz
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

5.  A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major.

Authors:  M Dimitriadou; A Christoforidis; L Fidani; M Economou; E Vlachaki; M Athanassiou-Metaxa; G Katzos
Journal:  Osteoporos Int       Date:  2015-08-15       Impact factor: 4.507

6.  Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women.

Authors:  E Bandrés; I Pombo; M González-Huarriz; A Rebollo; G López; J García-Foncillas
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

7.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

8.  A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression.

Authors:  Alanna Roff; Robin Taylor Wilson
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-06       Impact factor: 4.292

9.  Association of vitamin D receptor FokI and ApaI polymorphisms with lung cancer risk in Tunisian population.

Authors:  Wajih Kaabachi; Safa Kaabachi; Ahlem Rafrafi; Amira Ben Amor; Kalthoum Tizaoui; Faycal Haj Sassi; Kamel Hamzaoui
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

10.  Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India.

Authors:  Neetu Israni; Ravinder Goswami; Avinash Kumar; Rajni Rani
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.